Fig. 4From: High-content analysis identified synergistic drug interactions between INK128, an mTOR inhibitor, and HDAC inhibitors in a non-small cell lung cancer cell lineIsobologram of cell viability after drug combination treatment. Cells were treated with (A) AUY922 and SAHA, (B) INK128 and SAHA, or (C) INK128 and panobinostat, for 3 days and cell viability was measured by CCK8 luminescent assay. Relative growth value (left) was determined by comparing their growth with DMSO-treated cells or blank media. Mean values of relative growth were shown as a heatmap (n = 4). EOBs (right) were then calculated as previously and their values were also shown as a heatmap. Positive EOBs indicate synergism and negative EOBs indicate antagonismBack to article page